Anti-inflammatory and PPAR transactivational effects of components from the stem bark of ginkgo biloba

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 11, 2012, Pages 2815-2824

  Ngan, Nguyen Thi Thanh ^a   Quang, Tran Hong ^a,b   Tai, Bui Huu ^a   Song, Seok Bean ^a   Lee, Dongho ^c   Kim, Young Ho ^a  

^a Chungnam National University   (South Korea)

^b GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

^c Korea University   (South Korea)

Author keywords

GAL 4 PPAR chimera assay; Ginkgo biloba; NF B luciferase assay; PPRE luciferase assay; RT PCR

Indexed keywords

7 ,8-DIHYDRO; ANTI-INFLAMMATORIES; CIRCULAR DICHROISM SPECTRA; DIETARY SUPPLEMENTS; DIHYDROPHASEIC ACIDS; DOSE-DEPENDENT; DOSE-DEPENDENT MANNER; FUNCTIONAL FOODS; GINKGO BILOBA; HEPG2 CELLS; HERBAL PRODUCTS; INHIBITORY FUNCTION; LIVING FOSSILS; METABOLIC DISEASE; RT-PCR; SPECTROSCOPIC METHOD; STEM BARK; TRANSCRIPTIONAL ACTIVITY;

GENE EXPRESSION; SPECTROSCOPIC ANALYSIS;

PLANTS (BOTANY);

ANTIINFLAMMATORY AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLANT EXTRACT;

ARTICLE; CELL STRAIN HEPG2; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GINKGO BILOBA; HUMAN; IMMUNOLOGY; PLANT STEM; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS; GINKGO BILOBA; HEP G2 CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE II; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLANT EXTRACTS; PLANT STEMS; TRANSCRIPTIONAL ACTIVATION;

GINKGO BILOBA; HUMAN ECHOVIRUS 1;

EID: 84863338746     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf204768d     Document Type: Article

References (34)

1. Joyeux, M.; Lobstein, A.; Anton, R.; Mortier, F. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from ginkgo and some flavonoids Planta Med. 1995, 61, 126-129
2. Sticher, O. Quality of Ginkgo preparations Planta Med. 1993, 59, 2-11 (Pubitemid 23055637)
3. Singh, B.; Kaur, P.; Gopichand; Singh, R. D.; Ahuja, P. S. Biology and chemistry of Ginkgo biloba Fitoterapia 2008, 79, 401-418
4. Mahadevan, S.; Park, Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: Chemistry, efficacy, safety, and uses J. Food Sci. 2008, 73, R14-R19
5. Pande, V.; Ramos, M. J. NF-kB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors Curr. Med. Chem. 2005, 12, 357-374 (Pubitemid 40305625)
6. Baldwin, A. S., Jr. Series introduction: The transcription factor NF-kB and human disease J. Clin. Invest. 2001, 107, 3-6 (Pubitemid 32047404)
7. Berger, J.; Moller, D. E. The Mechanisms of action of PPARs Annu. Rev. Med. 2002, 53, 409-435 (Pubitemid 34177889)
8. Balint, B. L.; Nagy, L. Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases Endocr., Metab. Immune Disord.: Drug Targets 2006, 6, 33-43 (Pubitemid 43796712)
9. Barish, G. D.; Narkar, V. A.; Evans, R. M. PPAR d: A dagger in the heart of the metabolic syndrome J. Clin. Invest. 2006, 116, 590-597 (Pubitemid 43326863)
10. Haluzik, M. M.; Haluzik, M. PPAR- a and insulin sensitivity Physiol. Res. 2006, 55, 115-122
11. Kuroda, M.; Mimaki, Y.; Honda, S.; Tanaka, H.; Yokota, S.; Mae, T. Phenolics from Glycyrrhiza glabra roots and their PPAR-g ligand-binding activity Bioorg. Med. Chem. 2010, 18, 962-970
12. Shearer, B. G.; Billin, A. N. The next generation of PPAR drugs: Do we have the tools to find them? Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids 2007, 1771, 1082-1093 (Pubitemid 47202036)
13. Kim, K. K.; Park, K. S.; Song, S. B.; Kim, K. E. Up regulation of GW112 Gene by NFkB promotes an antiapoptotic property in gastric cancer cells Mol. Carcinog. 2010, 49, 259-270
14. Challice, J. S.; Loeffler, R. S. T.; Williams, A. H. Phenolic compounds of the genus Pyrus. Part 8. Structure of calleryanin and its benzylic esters from Pyrus and Prunus Phytochemistry 1980, 19, 2435-2437
15. Pan, H.; Lundgren, L. N. Phenolic extractives from root bark of Picea abies Phytochemistry 1995, 39, 1423-1428
16. Kanho, H.; Yaoya, S.; Kawahara, N.; Nakane, T.; Takase, Y.; Masuda, K.; Kuroyanagi, M. Biotransformation of benzaldehyde-type and acetophenone-type derivatives by Pharbitis nil hairy roots Chem. Pharm. Bull. 2005, 53, 361-365 (Pubitemid 40879871)
17. Yeo, H.; Chin, Y. W.; Park, S. Y.; Kim, J. Lignans of Rosa multiflora roots Arch. Pharm. Res. 2004, 27, 287-290 (Pubitemid 43073749)
18. Deyama, T.; Ikawa, T.; Nishibe, S. The constituents of Eucommia ulmoides Oliv. II. Isolation and structures of three new lignan glycosides Chem. Pharm. Bull. 1985, 33, 3651-3657 (Pubitemid 16235689)
19. Tokuoka, Y.; Daigo, K.; Takemoto, T. Constituents of Epimedium. III. Lignoids of Epimedium grandiflorum Yakugaku Zasshi 1975, 95, 557-563
20. 13C NMR spectral analysis of lignans from Araucaria angustifolia Phytochemistry 1978, 17, 499-502
21. Deyama, T. The Constituents of Eucommia ulmoides OLIV. I. Isolation of (+)-Medioresinol Di-O-b-D-glucopyranoside Chem. Pharm. Bull. 1983, 31, 2993-2997
22. Li, H. Z.; Luo, G. J.; Li, H. M.; Li, X. L.; Liz, R. T. A new aryltetrahydronaphthalene lignan from Epimedium brevicornum Chin. Chem. Lett. 2011, 22, 85-87
23. Lee, H.-J.; Lee, H.-J.; Je, K.-H.; Seo, J. K.; Lee, S. J.; Bang, S. L. Novel compound isolated from Ginkgo biloba bark, isolation method thereof and antiplatelet composition containing the same U.S. Pat. Appl. Publ. 2008, 14
24. van Beek, T. A. Ginkgolides and bilobalide: Their physical, chromatographic and spectroscopic properties Bioorg. Med. Chem. 2005, 13, 5001-5012 (Pubitemid 41039962)
25. del Refugio Ramos, M.; Jerz, G.; Villanueva, S.; Lopez-Dellamary, F.; Waibel, R.; Winterhalter, P. Two glucosylated abscisic acid derivates from avocado seeds (Persea americana Mill. Lauraceae cv. Hass) Phytochemistry 2004, 65, 955-962 (Pubitemid 38471778)
26. Lutz, A.; Winterhalter, P. Abscisic alcohol glucoside in quince Phytochemistry 1992, 32, 57-60
27. Baba, H.; Yaoita, Y.; Kikuchi, M. Constituents of the roots of Ligularia dentata Hara J. Nat. Med. 2007, 61, 472-473 (Pubitemid 47441014)
28. Kim, K. H.; Kim, H. K.; Choi, S. U.; Moon, E.; Kim, S. Y.; Lee, K. R. Bioactive lignans from the rhizomes of Acorus gramineus J. Nat. Prod. 2011, 74, 2187-2192
29. Wong, H. R.; Menendez, I. Y. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells Biochem. Biophys. Res. Commun. 1999, 262, 375-380 (Pubitemid 29429876)
30. Pahl, H. L. Activators and target genes of Rel/NF-kB transcription factors Oncogene 1999, 18, 6853-6866
31. Gross, B.; Staels, B. PPAR agonists: Multimodal drugs for the treatment of type-2 diabetes Best Pract. Res., Clin. Endocrinol. Metab. 2007, 21, 687-710 (Pubitemid 350177568)
32. Kaplan, F.; Al-Majali, K.; Betteridge, D. J. PPARS, insulin resistance and type 2 diabetes J. Cardiovasc. Risk 2001, 8, 211-217 (Pubitemid 32803675)
33. Moller, D. E. New drug targets for type II diabetes and the metabolic syndrome Nature 2001, 414, 821-827 (Pubitemid 34000786)
34. Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Monks, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Cancer Res. 1988, 48, 4827-4833